Abstract:In recent years, immunotherapy has developed rapidly as a new field of tumour therapy. However, the efficacy of tumour immunotherapy is not satisfactory due to the immune evasion mechanism of tumour cells, induction of immunosuppressive tumour microenvironment (TME), and reduction of antigen delivery, etc. CRISPR/Cas9 gene editing technology can accurately modify immune and tumour cells in tumours, and improve the efficacy of immunotherapy by targeting immune checkpoint molecules and immune regulatory genes, which has led to the great development and application. In current clinical trials, there are still many obstacles to the application of CRISPR/Cas9 in tumour immunotherapy, such as ensuring the accuracy and safety of gene editing, overcoming overreactive immune responses, and solving the challenges of in vivo drug delivery. Here we provide a systematic review on the application of CRISPR/Cas9 in tumour therapy to address the above existing problems. We focus on CRISPR/Cas9 screening and identification of immunomodulatory genes, targeting of immune checkpoint molecules, manipulation of immunomodulators, enhancement of tumour-specific antigen presentation and modulation of immune cell function. Second, we also highlight preclinical studies of CRISPR/Cas9 in animal models and various delivery systems, and evaluate the efficacy and safety of CRISPR/Cas9 technology in tumour immunotherapy. Finally, potential synergistic approaches for combining CRISPR/Cas9 knockdown with other immunotherapies are presented. This study underscores the transformative potential of CRISPR/Cas9 to reshape the landscape of tumour immunotherapy and provide insights into novel therapeutic strategies for cancer patients.

Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

Developing Pioneering Pharmacological Strategies with CRISPR/Cas9 Library Screening to Overcome Cancer Drug Resistance

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool

Targeted therapies for non-small cell lung cancer based on CRISPR-Cas9 technology

The Potential Revolution of Cancer Treatment with CRISPR Technology

Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review

Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment

CRISPR-Cas9-mediated gene therapy in lung cancer

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy

CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications

Gene editing using CRISPR-Cas9 for the treatment of lung cancer